Vitamin D Market Report 2026

The vitamin d market size has grown rapidly in recent years. It will grow from $1.79 billion in 2025 to $1.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing prevalence of vitamin d deficiency, growing awareness of bone-related disorders, rising consumption of dairy and fortified foods, expansion of pharmaceutical manufacturing, increased research on nutritional supplements.

The vitamin d market size is expected to see rapid growth in the next few years. It will grow to $2.92 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to adoption of personalized nutrition, growth of direct-to-consumer supplement platforms, advancements in vitamin d formulation technologies, increasing health-conscious population, expansion in emerging markets. Major trends in the forecast period include rising awareness of bone health, fortification of foods with vitamin d, personalized nutrition and supplementation, growth in pediatric and geriatric supplement use, expansion of online nutraceutical sales.

The increasing incidence of osteoporosis among women is expected to drive the growth of the vitamin D market. Osteoporosis is a bone disorder characterized by a decrease in bone mineral density and mass, along with changes in bone quality or structure. It is commonly caused by deficiencies in calcium and vitamin D, which raise the risk of fractures. Other contributing factors include a family history of osteoporosis, parental history of hip fractures, low body mass index (BMI), and female gender, as women generally have smaller and thinner bones than men. The growing prevalence of osteoporosis in women is expected to increase the demand for vitamin D, as it is a vital nutrient that helps the body absorb calcium and phosphorus from food and supports the development of stronger bones, particularly in postmenopausal women. It is also used in the treatment of conditions that lead to bone weakening. For example, in September 2023, according to the National Center for Biotechnology Information, a US-based government agency, data from the Canadian Longitudinal Study on Aging indicated that the prevalence of physician-diagnosed osteoporosis was 12.7%, while DXA-confirmed osteoporosis was 5.9% among community-dwelling older female adults. In addition, a cross-sectional study conducted by Buttros and colleagues reported a 24.6% prevalence of osteoporosis in postmenopausal women aged 40 to 75, based on bone mineral density (BMD) measurements. Consequently, the rising incidence of osteoporosis in women is fueling the growth of the vitamin D market.

Major companies operating in the vitamin D market are concentrating on the development of innovative solutions, such as fast-acting vitamin D formulations, to address the growing need for rapid correction of severe vitamin D deficiency and better treatment results. Fast-acting vitamin D products are formulated to raise serum vitamin D levels more quickly than conventional oral or oil-based formulations, providing improved absorption, a faster onset of action, and enhanced support for patients who require immediate replenishment. For example, in February 2024, Cadila Pharmaceuticals Ltd., an India-based pharmaceutical company, introduced an aqueous vitamin D injection. This novel aqueous formulation of cholecalciferol enables rapid correction of vitamin D deficiency, offering improved pharmacokinetic and pharmacodynamic properties compared to traditional oil-based formulations while ensuring painless administration. This innovation addresses the urgent demand for quicker therapeutic outcomes and enhances patient adherence to treatment regimens.

In April 2023, Innovad, a Belgium-based provider of animal nutrition and health solutions, acquired Herbonis AG for an undisclosed amount. Through this acquisition, Innovad seeks to reinforce its natural specialty feed ingredient portfolio by incorporating Herbonis’s plant-based vitamin D products, including Panbonis, and broadening its range of vitamin D supplementation solutions for animal nutrition. Herbonis AG is a Switzerland-based company that supplies plant-derived sources of the metabolically active form of vitamin D.

Major companies operating in the vitamin d market are BASF SE, Koninklijke DSM NV, Fermenta Biotech Ltd., Xiamen Kingdomway Vitamin Co. Ltd., Zhejiang Medicine Co. Ltd., Abbott Laboratories, Bayer AG, Bluebonnet Nutrition, Carlson Labs, Country Life LLC, Doctor's Best Inc., Douglas Laboratories, Garden of Life LLC, GlaxoSmithKline plc, Jarrow Formulas, Kirkland Signature, Life Extension, Merck & Co. Inc., Metagenics LLC, Pharmavite LLC, Nature's Bounty Co. Ltd., Nestlé Health Science SA, Pfizer Inc., Protocol for Life Balance Inc., Pure Encapsulations Inc., Sanofi S. A., Source Naturals Inc., Sundown Naturals Inc., Swanson Health Products Inc., Twinlab Consolidated Corporation, Vital Nutrients Company Inc.

North America was the largest region in the vitmain D market in 2025. The regions covered in the vitamin d market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vitamin d market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the vitamin D market by increasing import costs on raw materials and finished supplements, particularly impacting segments like high IU strength products and oil-based formulations. Regions such as North America and Europe, which rely on imported vitamin D, face higher costs, leading to price adjustments and supply chain diversification. Some manufacturers are localizing production, which mitigates supply risks and encourages domestic innovation. Additionally, tariffs can create opportunities for regional players to expand market share in areas less affected by import duties.

The vitamin d market research report is one of a series of new reports that provides vitamin d market statistics, including vitamin d industry global market size, regional shares, competitors with a vitamin d market share, detailed vitamin d market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin d industry. This vitamin d market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vitamin D is a nutrient required by the body in small amounts to function properly and maintain overall health. It plays a vital role in helping the body use calcium and phosphorus to build and maintain healthy bones and teeth. Vitamin D is fat-soluble and is found in foods such as dairy products, fatty fish, and egg yolks. It also contributes to maintaining proper bone structure and strength.

The primary types of vitamin D are vitamin D3 and vitamin D2. Vitamin D3 is mainly derived from animal-based sources such as fish oil, egg yolk, butter, and dietary supplements. Also known as cholecalciferol, it supports calcium absorption in the body and is commonly used to treat conditions such as osteomalacia and rickets. Vitamin D is available in three IU strengths, including 500,000 IU, 100,000 IU, and 40 MIU, and is offered in both oil and powder forms. It is used by adults, pregnant women, and children.

The vitamin D market consists of sales of ergocalciferol, cholecalciferol, and pre-vitamin D. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.